SCHEMBL3033576

SCHEMBL3033576

Cc1csc(C(=O)Cc2ccc3c(c2)OCO3)n1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.54
L3MBTL1 Q9Y468 4/20 0.53
LMNA P02545 4/20 0.53
NPC1 O15118 2/20 0.51
CYP3A4 P08684 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
HSD17B10 Q99714 2/20 0.48
TSHR P16473 2/20 0.48
TP53 P04637 1/20 0.48
ROCK1 Q13464 1/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
RAB9A P51151 2/20 0.47
HPGD P15428 1/20 0.47
EDNRB P24530 3/20 0.46
EDNRA P25101 3/20 0.46
TGFBR1 P36897 2/20 0.44
MAPK8 P45983 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13217615 0.77 NPC1 (0.62) KMT2AL3MBTL1LMNANPC1ALDH1A1
SCHEMBL7148530 0.74 CYP3A4 (0.72) KMT2AL3MBTL1LMNANPC1CYP3A4
SCHEMBL11694008 0.73 TDP1 (0.65) L3MBTL1LMNANPC1CYP3A4ALDH1A1
SCHEMBL13217620 0.73 NPC1 (0.49) KMT2AL3MBTL1LMNANPC1SMN1; SMN2
SCHEMBL4904756 0.72 ALDH1A1 (0.50) L3MBTL1LMNANPC1CYP3A4ALDH1A1
SCHEMBL109197 0.72 ALDH1A1 (0.64) KMT2AL3MBTL1LMNANPC1CYP3A4
SCHEMBL7495851 0.72 CYP3A4 (0.64) KMT2AL3MBTL1LMNANPC1CYP3A4
SCHEMBL30992968 0.72 CYP3A4 (0.68) L3MBTL1LMNANPC1CYP3A4ALDH1A1
SCHEMBL547618 0.72 CYP3A4 (0.68) L3MBTL1LMNANPC1CYP3A4ALDH1A1
SCHEMBL25201619 0.71 HPGD (0.67) KMT2AL3MBTL1LMNANPC1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216787-A1 THIAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2010-08-26 US disclosed
US-7678810-B2 Thiazole derivative TAISHO PHARMACEUTICAL CO., LTD (JP) 2010-03-16 US disclosed
US-20070154428-A1 Thiazole derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2007-07-05 US disclosed
EP-1721905-A1 THIAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-11-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216787-A1 THIAZOLE DERIVATIVE TGFBR1, TGFBR2, SMAD3 KMT2A 2374/4885L3MBTL1 3693/4885LMNA 4575/4885
US-20070154428-A1 Thiazole derivative TGFBR1, TGFBR2, SMAD3 KMT2A 2374/4885L3MBTL1 3693/4885LMNA 4575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.